Last10K.com

Affymax Inc (AFFY) SEC Filing 10-K Annual report for the fiscal year ending Tuesday, December 31, 2013

Affymax Inc

CIK: 1158223 Ticker: AFFY
Document and Entity Information (USD $)
12 Months Ended
Dec. 31, 2013
Feb. 28, 2014
Jun. 30, 2013
Entity Information [Line Items]      
Entity Registrant Name AFFYMAX INC    
Entity Central Index Key 0001158223    
Document Type 10-K    
Document Period End Date Dec. 31, 2013    
Amendment Flag false    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Filer Category Non-accelerated Filer    
Entity Public Float     $ 463,771,551
Entity Common Stock, Shares Outstanding   37,490,095  
Document Fiscal Year Focus 2013    
Document Fiscal Period Focus FY    

View differences made from one year to another to evaluate Affymax Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Affymax Inc.

Continue

Assess how Affymax Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Affymax Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2014 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Balance Sheets
Balance Sheets (parenthetical)
Statement Of Operations
Statement Of Stockholders' Equity
Statements Of Cash Flows
Statements Of Comprehensive Loss
Balance Sheet Components
Balance Sheet Components (accrued Liabilities) (details)
Balance Sheet Components (property And Equipment, Net) (details)
Balance Sheet Components (tables)
Commitments And Contingencies
Commitments And Contingencies (tables)
Commitments And Contingencies Commitments And Contingencies (details Textual)
Contractual Arrangements
Contractual Arrangements (details)
Development And Commercialization Agreements With Takeda
Development And Commercialization Agreements With Takeda (details)
Fair Value Measurements
Fair Value Measurements (details)
Fair Value Measurements (tables)
Income Taxes
Income Taxes (deferred Tax Assets) (details)
Income Taxes (details Textual)
Income Taxes (provision For Income Taxes) (details)
Income Taxes (reconciliation Of Federal Statutory Income Tax Rate) (details)
Income Taxes (reconciliation Of Unrecognized Tax Benefits) (details)
Income Taxes (tables)
Investments
Investments (details)
Investments (tables)
Loan And Security Agreement
Loan And Security Agreement (details)
Quarterly Financial Data
Quarterly Financial Data (details Textual)
Quarterly Financial Data (details)
Quarterly Financial Data (tables)
Restructuring Charge
Restructuring Charge (details)
Restructuring Charge (tables)
Retirement Savings Plan
Retirement Savings Plan (details)
Stock-based Compensation
Stock-based Compensation (details Textual)
Stock-based Compensation (details)
Stock-based Compensation (restricted Stock Unit Activity) (details)
Stock-based Compensation (statements Of Operaitons) (details)
Stock-based Compensation (stock Options Outstanding And Exercisable) (details)
Stock-based Compensation (stock Options) (details)
Stock-based Compensation (tables)
Stockholder's Equity
Stockholder's Equity (details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (concentration Of Risk) (details)
Summary Of Significant Accounting Policies (inventory) (details)
Summary Of Significant Accounting Policies (net Loss Per Common Share) (details)
Summary Of Significant Accounting Policies (policies)
Summary Of Significant Accounting Policies (property And Equipment) (details)
Summary Of Significant Accounting Policies (revenue Recognition) (details)
Summary Of Significant Accounting Policies (tables)
The Company
The Company (details)
Ticker: AFFY
CIK: 1158223
Form Type: 10-K Annual Report
Accession Number: 0001445305-14-001231
Submitted to the SEC: Mon Mar 31 2014 4:44:08 PM EST
Accepted by the SEC: Mon Mar 31 2014
Period: Tuesday, December 31, 2013
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/affy/0001445305-14-001231.htm